Warning letter
Chang and Son Enterprises, Inc.: warning letter of May 31, 2024
FDA warning letter 679517 · Division of Human and Animal Food Operations East I
Key facts
| Reference number | 679517 |
|---|---|
| Company | Chang and Son Enterprises, Inc. |
| Subject | CGMP/Food/Prepared, Packed or Held Under Insanitary Conditions/Adulterated/L. monocytogenes |
| Issue date | May 31, 2024 |
| Posted date | Jun 18, 2024 |
| Issuing office | Division of Human and Animal Food Operations East I |
| Product type | Food/Cosmetics |
| CFR sections cited | 112 |
| Inspection city | Whately |
| Inspection ZIP | 01093 |
| Inspection start date | Jan 10, 2024 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: